Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction
- 1 August 2018
- journal article
- research article
- Published by Elsevier in JACC: Heart Failure
- Vol. 6 (8) , 689-697
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Atrial Fibrillation and Outcomes in Heart Failure With Preserved Versus Reduced Left Ventricular Ejection FractionJournal of the American Heart Association, 2013
- Eplerenone and Atrial Fibrillation in Mild Systolic Heart FailureJACC, 2012
- Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007Circulation: Cardiovascular Quality and Outcomes, 2012
- Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fractionAmerican Heart Journal, 2011
- Absolute and Attributable Risks of Atrial Fibrillation in Relation to Optimal and Borderline Risk FactorsCirculation, 2011
- Effect of Combined Spironolactone–β-Blocker ± Enalapril Treatment on Occurrence of Symptomatic Atrial Fibrillation Episodes in Patients With a History of Paroxysmal Atrial Fibrillation (SPIR-AF Study)The American Journal of Cardiology, 2010
- Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort studyThe Lancet, 2009
- Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection FractionNew England Journal of Medicine, 2006
- Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programAmerican Heart Journal, 2006
- Atrial Fibrillation and Risk of Clinical Events in Chronic Heart Failure With and Without Left Ventricular Systolic DysfunctionJACC, 2006